Bureaucrats, developer, Administrators
9,842
edits
User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions
User:Jukeboksi/Wiki.study/Natural therapeutics (edit)
Revision as of 12:06, 16 July 2020
, 16 July 2020→Brain cancer and cannabis: + a 2001 study published in w:Cancer Research (journal) titled 'Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor'
(→Brain cancer and cannabis: + a 2004 study, published in w:Journal of Pharmacology and Experimental Therapeutics titled 'Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines') |
(→Brain cancer and cannabis: + a 2001 study published in w:Cancer Research (journal) titled 'Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor') |
||
| Line 217: | Line 217: | ||
* [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors'], a 2018 perspective article | * [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors'], a 2018 perspective article | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/20307616 'Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2010 comparative study, published in [[w:Neurochemistry International]] | * [http://www.ncbi.nlm.nih.gov/pubmed/20307616 'Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2010 comparative study, published in [[w:Neurochemistry International]] | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/17675107 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 '''clinical trial''', published in [[w:Neuropharmacology (journal)]] | * [http://www.ncbi.nlm.nih.gov/pubmed/17675107 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 '''clinical trial''', published in [[w:Neuropharmacology (journal)]] | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/19480992 'Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 study, published in [[w:Brain Research Bulletin]] | * [http://www.ncbi.nlm.nih.gov/pubmed/19480992 'Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 study, published in [[w:Brain Research Bulletin]] | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/17952650 'Cannabinoids and gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2007 '''review''', published in [[w:Molecular Neurobiology (journal)]] | * [http://www.ncbi.nlm.nih.gov/pubmed/17952650 'Cannabinoids and gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2007 '''review''', published in [[w:Molecular Neurobiology (journal)]] | ||
* [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089 'Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, 2005 study, published in [[w:British Journal of Pharmacology]] | * [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089 'Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, 2005 study, published in [[w:British Journal of Pharmacology]] | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/15275820 'Hypothesis: cannabinoid therapy for the treatment of gliomas?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2004 '''review''', published in [[w:Neuropharmacology (journal)]] | * [http://www.ncbi.nlm.nih.gov/pubmed/15275820 'Hypothesis: cannabinoid therapy for the treatment of gliomas?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2004 '''review''', published in [[w:Neuropharmacology (journal)]] | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/14617682 'Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2004 study, published in [[w:Journal of Pharmacology and Experimental Therapeutics]] | * [http://www.ncbi.nlm.nih.gov/pubmed/14617682 'Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2004 study, published in [[w:Journal of Pharmacology and Experimental Therapeutics]] | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/11479216 'Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2001 study published in [[w:Cancer Research (journal)]] | |||